LEPU BIOPHARMA CO LTD revenue for the last year amounted to 247.92 M HKD, the most of which — 249.01 M HKD — came from its highest performing source at the moment, Drugs for Cancer Targeted Therapy and Immunotherapy, the year earlier bringing 18.11 M HKD. The greatest contribution to the revenue figure was made by China — last year it brought LEPU BIOPHARMA CO LTD 249.01 M HKD, and the year before that — 18.11 M HKD.